Status:
COMPLETED
App Reminder on ASA Adherence
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Association of Orthopaedic Nurses
Conditions:
Thromboembolic Event
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic t...
Detailed Description
The purpose of this study is to evaluate the impact of using a smartphone application (app) reminder on medication adherence twice daily in 200 adults prescribed 81 milligrams of aspirin (ASA) for 35 ...
Eligibility Criteria
Inclusion
- Prescribed aspirin 81 mg twice a day for 35 days
- Ability to write and speak English
- Have a smart phone with the capacity to download and set an app
- Own and use a smart phone for communication purposes
Exclusion
- Diagnosis of mental illness
- Do not own a smart phone
Key Trial Info
Start Date :
October 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2019
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT03244267
Start Date
October 3 2017
End Date
March 8 2019
Last Update
October 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Orthopedic and Spine Hospital
Atlanta, Georgia, United States, 30084